Caribou Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRBU and other ETFs, options, and stocks.About CRBU
Caribou Biosciences, Inc. engages in the development of an internal pipeline of off-the-shelf CAR-T and CAR-NK cell therapies. Its tools and technologies provide transformative capabilities to basic and applied biological research, therapeutic development, agricultural biotechnology, and industrial biotechnology.
CEORachel E. Haurwitz
CEORachel E. Haurwitz
Employees147
Employees147
HeadquartersBerkeley, California
HeadquartersBerkeley, California
Founded2011
Founded2011
Employees147
Employees147
CRBU Key Statistics
Market cap200.68M
Market cap200.68M
Price-Earnings ratio-1.22
Price-Earnings ratio-1.22
Dividend yield—
Dividend yield—
Average volume7.90M
Average volume7.90M
High today$2.32
High today$2.32
Low today$2.09
Low today$2.09
Open price$2.28
Open price$2.28
Volume1.36M
Volume1.36M
52 Week high$3.54
52 Week high$3.54
52 Week low$0.66
52 Week low$0.66
Stock Snapshot
As of today, Caribou Biosciences(CRBU) shares are valued at $2.16. The company's market cap stands at 200.68M, with a P/E ratio of -1.22.
As of 2025-11-05, Caribou Biosciences(CRBU) stock has fluctuated between $2.09 and $2.32. The current price stands at $2.16, placing the stock +3.1% above today's low and -7.1% off the high.
The Caribou Biosciences(CRBU)'s current trading volume is 1.36M, compared to an average daily volume of 7.9M.
In the last year, Caribou Biosciences(CRBU) shares hit a 52-week high of $3.54 and a 52-week low of $0.66.
In the last year, Caribou Biosciences(CRBU) shares hit a 52-week high of $3.54 and a 52-week low of $0.66.
Analyst ratings
100%
of 8 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own CRBU. This list is generated using Robinhood data, and it’s not a recommendation.